Treatment of panic and agoraphobia an integrative review

Journal of Nervous and Mental Disease

Volumn 178, Issue 9, 1990, Pages 564-576

  Mattick, Richard P ^a,b   Andrews, Gavin ^a   Hadzi Pavlovic, Dusan ^a   Christensen, Helen ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Social Psychiatry Research Unit ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; IMIPRAMINE;

AGORAPHOBIA; ANXIETY; BEHAVIOR THERAPY; EXPOSURE; HUMAN; PANIC; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; THEORETICAL STUDY;

AGORAPHOBIA; ALPRAZOLAM; ANXIETY DISORDERS; BEHAVIOR THERAPY; BIBLIOGRAPHY; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEAR; FOLLOW-UP STUDIES; HUMAN; IMIPRAMINE; META-ANALYSIS; PANIC; PLACEBOS; SUPPORT, NON-U.S. GOV'T;

EID: 0025034230     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Andrews G (1983) Psychotherapy outcome: A wider view leads to different conclusions. Behav Brain Sci 6:285-286.
2. Andrews G (1984) On the promotion of non-drug treatments. Br Med J 289:994-995.
3. Andrews G, Harvey R (1981) Does psychotherapy benefit neurotic patients? A reanalysis of the Smith, Glass, and Miller data. Arch Gen Psychiatry 38:1203-1208.
4. Andrews G, MacMahon SW, Austin A, Byrne DB (1982) Hypertension: Comparison of drug and non drug treatments. Br Med J 284:1523-1526.
5. Andrews G, Moran C (1988) The treatment of agoraphobia with panic attacks: Are drugs essential? In I Hand, H-U Wittchen (Eds), Panic and phobias 2: Treatments and variables affecting course and outcome (pp 89-99). Berlin: Springer-Verlag.
6. Andrews G, Pollack C, Stewart G (1989) The determination of defense style by questionnaire. Arch Gen Psychiatry 46:455-460.
7. Bangert-Drowns RL (1986) Review of developments in meta-analytic method. Psychol Bull 99:388-399.
8. Barlow DH (1988) Anxiety and its disorders: The nature and treatment of anxiety and panic. New York: Guilford.
9. Barlow DH, Gerny J A. 1989. Psychological treatment of panic. New York: Guilford.
10. Charney DS, Woods SW, Goodman WR, et al (1987, May 13) The efficacy of lorazepam in panic disorders (New Research Abstract 165) Proceedings of the 140th Annual Meeting of the American Psychiatric Association, Chicago.
11. Christensen H, Hadzi-Pavlovic D, Andrews G, et al (1987) Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: A quantitative review. J Consult Clin Psychol 55:701-711.
12. Clark DM, Salkovskis PM, Gelder M, et al (1988) Tests of a cognitive theory of panic. In I Hand, H-U Wittchen (Eds), Panic and phobias 2: Treatments and variables affecting course and outcome (pp 149-158). Berlin: Springer-Verlag.
13. Cophen J (1962) The statistical power of abnormal-social psychological research: A review. J Abnorm Soc Psychol 65:145-153.
14. Fontaine R (1985) Clonazepam for panic disorders and agitation. Psychosomatics 26(12 Suppl):13-16.
15. Fyer AJ (1988) Effects of discontinuation of antipanic medication.
16. Fyer AJ, Liebowitz MR, Gorman JM, et al (1987) Discontinuation of alprazolam treatment in panic patients. Am J Psychiatry 144:303-308.
17. Garakani H, Zitrin CM, Klein MD (1984) Treatment of panic disorder with imipramine alone. Am J Psychiatry 141:446.
18. Glass GV (1976) Primary, secondary and meta-analysis of research. Educ Res 5:3-8.
19. Glass GV, McGaw B, Smith MLK (1981) Metaanalysis in social research0. Beverly Hills, CA: Sage.
20. Goldstein AJ, Chambless DL (1978) A reanalysis of agoraphobia. Behav Res Ther 9:47-59.
21. Hedges LV (1981) Distribution theory for Glass's estimator of effect size and related estimators. J Educ Statistics 6:107-128.
22. Kazdin AE (1983) Meta-analysis of psychotherapy: Criteria for selecting investigations. Behav Brain Sci 6:296.
23. Kelly D, Guirguis W, Frommer E, et al (1970) Treatment of phobic states with antidepressants: A retrospective study of246 patients. Br J Psychiatry 116:387-398.
24. Klein DF (1980) Anxiety reconceptualized. Compr Psychiatry 21:411-414.
25. Klein DF (1981) Anxiety reconceptualized. In DF Klein, JG Rabkin (Eds), Anxiety: New research and changing concepts. New York: Raven.
26. Klein DF, Ross DC, Cohen P (1987) Panic and avoidance in agoraphobia: Application of path analysis to treatment studies. Arch Gen Psychiatry 44:377-385.
27. Kraemer HC, Andrews G (1982) A non-parametric technique for meta-analysis effect size calculations. Psychol Bull 91:404-412.
28. Light RJ, Pillemer DB (1984) Summing up: The science of reviewing research. Cambridge, MA: Harvard University Press.
29. Lipsedge MS, Hajioff F, Huggins P, et al (1973) The management of severe agoraphobia: A comparison of iproniazid and systematic desensitization. Psychopharmacolgia 32:67-80.
30. Marks IM (1987) Fears phobias, and rituals: Panic, anxiety, and their disorders. Oxford, UK: Oxford University Press.
31. Mattick RP, Peters L (1988) Treatment of severe social phobia: Effects of guided exposure with and without cognitive restructuring. J Consult Clin Psychol 56:251-260.
32. Mavissakalian M (1986) Clinically significant improvement in agoraphobia research. Behav Res Ther 24:369-370.
33. McNair DM, Kahn RJ (1981) Imipramine compared with a benzodiazepine for agoraphobia. In DF Klein, J Rabkin (Eds), Anxiety: New research and changing concepts (pp. 69-80). New York: Raven.
34. Michelson L, Mavissakalian M (1983) Temporal stability of self-report measures in agoraphobia research. BehavRes Ther 21:695-698.
35. Moran C, Andrews G (1985) Familial occurrence of agoraphobia. Br J Psyciatry 146:262-267.
36. Pollack MH, Tesar GE, Rosenbaum JF, et al (1986) Clonazepam in the treatment of panic disorder and agoraphobia: A one-year follow-up. J Clin Psychopharmacol 6:302-304.
37. Quality Assurance Project (1985) Treatment outlines for the management of anxiety states. Aust NZ J Psychiatry 19:138-151.
38. Sheehan DV (1982) Panic attacks and phobias. N Engl J Med 307:156-158.
39. Sheehan DV (1987) Benzodiazepines in panic disorder and agoraphobia. J Affective Disord 13:169-181.
40. Smith ML, Glass GV, Miller TI (1980) The benefits of psychotherapy. Baltimore: John Hopkins University Press.
41. Solyom L, Heseltine GFD, McClure DJ, et al (1973) Behaviour therapy versus drug therapy in the treatment of phobic neurosis. Can Psychiatr Assoc J 18:25-32.
42. Tesar GE, Rosenbaum JF, Pollack MH, et al (1987) Clonazepam versus alprazolam in the treatment of panic disorder: Interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry 48(10 Suppl): 16-19.
43. Tyrer P (1988a) Prescribing psychotropic drugs in general practice. Br Med J 296:588-589.
44. Tyrer P (1988b) Legal repercussions in prescribing benzodiazepines. Bull R Coll Psychiatr 12:190.
45. Tyrer P, Candy J, Kelly D (1973) A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psy-chopharmacologia 32:237-254.
46. Weissman MM, Merikangas KR (1986) The epidemiology of anxiety and panic disorder. J Clin Psychiatry 47(Suppl): 11-17.
47. Zitrin CM, Klein DF, Woerner MG (1980) Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 37:63-72.